New weight-loss pill hits the market, promising ‘greater flexibility’
“People living with obesity need treatment options that meet them where they are – and for many, a once-daily pill that can be taken with no food or water restrictions can offer them greater flexibility in how they approach their treatment,” she said in the same press release.
The once-daily pill works best when partnered with a reduced-calorie diet and increased physical activity, the manufacturer states. (iStock)
David A. Ricks, chair and CEO of Eli Lilly and Company, also commented on the importance of new treatment options.
CLICK HERE FOR MORE HEALTH STORIES
“Today, fewer than one in 10 people who could benefit from a GLP-1 are taking one, held back by access, stigma, perceived complexity, or the belief that their condition isn’t serious enough for treatment,” he said in the release. “We believe Foundayo can help level the playing field for those living with obesity or who are overweight and living with weight-related complications.”
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Lilly does not recommend using Foundayo in combination with other GLP-1 drugs. It is also unclear whether the medication is safe for children.
The drug will be ready to ship to patients on April 6, Lilly stated. (Scott Olson/Getty Images)
The drugmaker warned that the treatment could cause tumors in the thyroid, including thyroid cancer, warning patients to monitor symptoms such as a lump or swelling in the neck, hoarseness, trouble swallowing or shortness of breath.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Similar to other GLP-1s, the most common side effects of Foundayo are gastrointestinal in nature, including nausea, constipation, diarrhea, vomiting, indigestion, stomach pain, headache, swollen belly, fatigue, belching, heartburn, gas and hair loss.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Lilly recommends speaking with a healthcare provider before taking Foundayo to share other medications and family health history that may increase the risk of complications.
Fox News Digital reached out to Lilly for comment.
Angelica Stabile is a lifestyle reporter for Fox News Digital.
Article source: https://www.foxnews.com/health/new-weight-loss-pill-hits-market-promising-greater-flexibility